About this event

Speakers

  • Dr. Peter B. Bach, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Gardiner Harris, Resident Fellow, The German Marshall Fund of the United States; Former Diplomatic, Public Health, and Pharmaceutical Correspondent, The New York Times

Moderator

  • Sudha David-Wilp, Senior Transatlantic Fellow and Deputy Director of the Berlin office, The German Marshall Fund of the United States

As temperatures rise and new coronavirus cases plateau in some areas of the United States, federal and local officials are contemplating and beginning to implement steps to ease lockdown measures. Yet, a return to the pre-crisis normal is still far off. While the global race for a successful vaccine continues, experts warn that it is unlikely to be available before the end of the year. At least until then, U.S. citizens will have to be prepared for severe limitations to daily life or risk a crisis resurgence.

Join us for a conversation with health and pharmaceutical experts to discuss "the new normal" in times of a global pandemic and to assess what the coming months may bring. 

Due to concerns about the coronavirus and in order to enable a wider audience to participate in this discussion, we invite you to join us via webinar. Please register to join the conversation and take part in the Q&A with the panelists.

If you have any questions regarding the event, please contact Itai Barsade at [email protected]